RESEARCHER PROFILE

Matthew Cramp

← Back to University of Plymouth

M

University of Plymouth

Hepatitis C virus researchLiver Disease and TransplantationHepatitis B Virus StudiesOrgan Transplantation Techniques and OutcomesHelicobacter pylori-related gastroenterology studies

Matthew Cramp works in Hepatitis C virus research, Liver Disease and Transplantation, Hepatitis B Virus Studies, Organ Transplantation Techniques and Outcomes, Helicobacter pylori-related gastroenterology studies. Recorded institutional associations include Plymouth Hospital, University Hospitals Plymouth NHS Trust, University of Plymouth.

166Publications
10,230Citations
41H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    2016 · 2,006 citations

  2. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 1,976 citations

  3. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

    2004 · 1,179 citations

  4. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

    2022 · 641 citations

  5. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

    2014 · 602 citations

  6. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 533 citations

  7. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    2021 · 492 citations

  8. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

    2014 · 477 citations

  9. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

    2023 · 441 citations

  10. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2022 · 369 citations

  11. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    2022 · 324 citations

  12. Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C

    2000 · 313 citations

  13. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 290 citations

  14. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

    2015 · 286 citations

  15. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    2017 · 267 citations

  16. Historical epidemiology of hepatitis C virus ( HCV ) in selected countries

    2014 · 261 citations

  17. Non–Travel‐Associated Hepatitis E in England and Wales: Demographic, Clinical, and Molecular Epidemiological Characteristics

    2005 · 231 citations

  18. Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts

    2013 · 212 citations

  19. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

    2019 · 206 citations

  20. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

    2007 · 195 citations

  21. Strategies to manage hepatitis C virus ( HCV ) disease burden

    2014 · 185 citations

  22. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

    2021 · 182 citations

  23. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK

    2017 · 169 citations

  24. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

    1998 · 161 citations

  25. Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus†

    2009 · 157 citations

← Return to the university profile